Here are six updates on GI companies from the past week.
Physicians Endoscopy celebrated its 20th anniversary Feb. 7.
Exact Sciences acquired Armune BioScience, a life sciences startup that developed a diagnostic blood test for prostate cancer.
Adhesys Medical, a wholly owned subsidiary of Grünenthal Group, received the FDA's Expedited Access Pathway designation for the surgical sealant Vivo.
Clinical Genomics' fecal occult blood test was found to be 'significantly more' sensitive than competitors.
Allegan, Forest Laboratories and Ironwood Pharmaceuticals accused Sandoz of patent infringement in a lawsuit to prevent Sandoz from bringing a generic version of Linzess to market.
The FDA approved the radioactive drug Lutathera for the treatment of gastroenteropancreatic neuroendocrine tumors. This is the first time a radiopharmaceutical has been approved for the treatment of GEP-NETs.